Vericiguat in heart failure patients: analyzing safety, tolerability, and quality of life via meta-analysis of randomized controlled trials

Basit Öğe Kaydı
dc.contributor.authorTanriverdi, L. H.
dc.contributor.authorDogan, M. M.
dc.contributor.authorBanach, M.
dc.date.accessioned2026-04-04T13:33:31Z
dc.date.available2026-04-04T13:33:31Z
dc.date.issued2024
dc.departmentİnönü Üniversitesi
dc.descriptionEuropean-Society-of-Cardiology Congress (ESC) -- AUG 30-SEP 02, 2024 -- London, ENGLAND
dc.description.abstract[No abstract available]
dc.description.sponsorshipEuropean Soc Cardiol
dc.identifier.doi10.1093/eurheartj/ehae666.1082
dc.identifier.issn0195-668X
dc.identifier.issn1522-9645
dc.identifier.orcid0000-0003-4263-5234
dc.identifier.urihttps://doi.org/10.1093/eurheartj/ehae666.1082
dc.identifier.urihttps://hdl.handle.net/11616/109190
dc.identifier.volume45
dc.identifier.wosWOS:001345267600023
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.ispartofEuropean Heart Journal
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250329
dc.titleVericiguat in heart failure patients: analyzing safety, tolerability, and quality of life via meta-analysis of randomized controlled trials
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu